Effect of Yoghurt Fortified with Probiotics and Vitamins D and E in Treatment of Polycystic Ovary Syndrome

Phase 3

Recruiting

• Conditions: Polycystic ovary syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20231210060323N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

Willingness to cooperate in the study and provide written consent
Being in the reproductive age range of 18-45 years
Diagnosis of polycystic ovary syndrome based on the Rotterdam criteria
No intake of alcohol or drugs
Not pregnant or breastfeeding
No menopause
No participate in other research studies

Exclusion Criteria

Using drugs affecting blood pressure, blood lipids, ovarian function, insulin sensitivity (including metformin, incretin, and Thiazolidinediones) and oral contraceptives (including progesterone and estrogen) since 3 months before entering the study.
Taking any nutritional supplements for 3 months before entering the study
Taking drugs affecting vitamin D metabolism
having diabetes, thyroid disease or any systemic disease (such as kidney, liver, digestive system, cardiovascular system)
Having disorders that lead to an increase in androgens in the blood (such as Cushing's syndrome, hyperprolactinemia)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Homeostasis model assessment of insulin resistance. Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study (8 weeks after the start of the intervention). Method of measurement: Formula.